267 related articles for article (PubMed ID: 27473149)
1. The phosphatase calcineurin regulates pathological TDP-43 phosphorylation.
Liachko NF; Saxton AD; McMillan PJ; Strovas TJ; Currey HN; Taylor LM; Wheeler JM; Oblak AL; Ghetti B; Montine TJ; Keene CD; Raskind MA; Bird TD; Kraemer BC
Acta Neuropathol; 2016 Oct; 132(4):545-61. PubMed ID: 27473149
[TBL] [Abstract][Full Text] [Related]
2. Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes.
Neumann M; Frick P; Paron F; Kosten J; Buratti E; Mackenzie IR
Acta Neuropathol; 2020 Nov; 140(5):645-658. PubMed ID: 32778941
[TBL] [Abstract][Full Text] [Related]
3. Genome wide analysis reveals heparan sulfate epimerase modulates TDP-43 proteinopathy.
Liachko NF; Saxton AD; McMillan PJ; Strovas TJ; Keene CD; Bird TD; Kraemer BC
PLoS Genet; 2019 Dec; 15(12):e1008526. PubMed ID: 31834878
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43.
King A; Maekawa S; Bodi I; Troakes C; Al-Sarraj S
Neuropathology; 2011 Jun; 31(3):239-49. PubMed ID: 21118398
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy.
Liachko NF; Guthrie CR; Kraemer BC
J Neurosci; 2010 Dec; 30(48):16208-19. PubMed ID: 21123567
[TBL] [Abstract][Full Text] [Related]
6. Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration.
Yousef A; Robinson JL; Irwin DJ; Byrne MD; Kwong LK; Lee EB; Xu Y; Xie SX; Rennert L; Suh E; Van Deerlin VM; Grossman M; Lee VM; Trojanowski JQ
Acta Neuropathol Commun; 2017 Sep; 5(1):68. PubMed ID: 28877758
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models.
Coudert L; Nonaka T; Bernard E; Hasegawa M; Schaeffer L; Leblanc P
Cell Mol Life Sci; 2019 Jul; 76(13):2615-2632. PubMed ID: 30863908
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates.
Laferrière F; Maniecka Z; Pérez-Berlanga M; Hruska-Plochan M; Gilhespy L; Hock EM; Wagner U; Afroz T; Boersema PJ; Barmettler G; Foti SC; Asi YT; Isaacs AM; Al-Amoudi A; Lewis A; Stahlberg H; Ravits J; De Giorgi F; Ichas F; Bezard E; Picotti P; Lashley T; Polymenidou M
Nat Neurosci; 2019 Jan; 22(1):65-77. PubMed ID: 30559480
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis.
Tan RH; McCann H; Shepherd CE; Pinkerton M; Mazumder S; Devenney EM; Adler GL; Rowe DB; Kril J; Halliday GM; Kiernan MC
Acta Neuropathol Commun; 2023 Nov; 11(1):180. PubMed ID: 37957721
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes.
Takeuchi R; Tada M; Shiga A; Toyoshima Y; Konno T; Sato T; Nozaki H; Kato T; Horie M; Shimizu H; Takebayashi H; Onodera O; Nishizawa M; Kakita A; Takahashi H
Acta Neuropathol Commun; 2016 Jun; 4(1):61. PubMed ID: 27338935
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of phosphorylated TDP-43 in the CNS of a patient with Cockayne syndrome.
Sakurai A; Makioka K; Fukuda T; Takatama M; Okamoto K
Neuropathology; 2013 Dec; 33(6):673-7. PubMed ID: 23581709
[TBL] [Abstract][Full Text] [Related]
12. [Neuropathology of TDP-43 proteinopathy].
Akiyama H; Hasegawa M
Brain Nerve; 2013 Dec; 65(12):1477-89. PubMed ID: 24323933
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and pathological spectrum of TDP-43 associated ALS].
Onodera O; Yokoseki A; Tan CF; Ishihara T; Nishiira Y; Toyoshima Y; Kakita A; Nishizawa M; Takahashi H
Rinsho Shinkeigaku; 2010 Nov; 50(11):940-2. PubMed ID: 21921519
[TBL] [Abstract][Full Text] [Related]
14. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy.
Chew J; Cook C; Gendron TF; Jansen-West K; Del Rosso G; Daughrity LM; Castanedes-Casey M; Kurti A; Stankowski JN; Disney MD; Rothstein JD; Dickson DW; Fryer JD; Zhang YJ; Petrucelli L
Mol Neurodegener; 2019 Feb; 14(1):9. PubMed ID: 30767771
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated TDP-43 localizes to chronic cerebral infarctions in human brains.
Umahara T; Uchihara T; Hirao K; Shimizu S; Hanyu H
Histol Histopathol; 2020 Sep; 35(9):1023-1028. PubMed ID: 32557523
[TBL] [Abstract][Full Text] [Related]
16. PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies.
Lee S; Jeon YM; Cha SJ; Kim S; Kwon Y; Jo M; Jang YN; Lee S; Kim J; Kim SR; Lee KJ; Lee SB; Kim K; Kim HJ
Autophagy; 2020 Aug; 16(8):1396-1412. PubMed ID: 31690171
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
[TBL] [Abstract][Full Text] [Related]
18. [A new dementia group caused by TDP-43 abnormality].
Arai T; Hosokawa M; Hasegawa M; Akiyama H; Asada T
Seishin Shinkeigaku Zasshi; 2011; 113(6):574-83. PubMed ID: 21815469
[TBL] [Abstract][Full Text] [Related]
19. Disease animal models of TDP-43 proteinopathy and their pre-clinical applications.
Liu YC; Chiang PM; Tsai KJ
Int J Mol Sci; 2013 Oct; 14(10):20079-111. PubMed ID: 24113586
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions.
Mori F; Tada M; Kon T; Miki Y; Tanji K; Kurotaki H; Tomiyama M; Ishihara T; Onodera O; Kakita A; Wakabayashi K
Acta Neuropathol Commun; 2019 Oct; 7(1):165. PubMed ID: 31661037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
